DRUG

ibrutinib

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for ibrutinib

Multiple sclerosis 2

Mediator Outcome Score Tier Lit. status Trial
BTK chronic active lesions 0.208 Mid novel signal none
BTK active lesions 0.208 Mid novel signal none

Clinical trials

200 registered trials for ibrutinib

Source: ClinicalTrials.gov

← All drugs